Article
Interleukin-2 immunotherapy reveals human regulatory T cell subsets with distinct functional and gatekeeper features
2022-11-15
Abstract excerpt
<h4>ABSTRACT</h4> Due to its stimulatory potential for immunomodulatory CD4 + regulatory T (Treg) cells, low-dose interleukin-2 (IL-2) immunotherapy has recently gained considerable attention for treatment of various autoimmune diseases. Although early-stage clinical trials have correlated expansion of circulating Treg cells with clinical response to IL-2 treatment, detailed mechanistic data on responding Treg cel...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b04cde8e-8ec8-5a1b-aa26-1fe725be77a8
- DOI
- 10.1101/2022.11.15.22282201
